BridgeBio Pharma participated in a series B round for its subsidiary Eidos Therapeutics, which is working on treatments for a family of rare genetic diseases known as ATTR.

6 River Systems is working on robotics technology to handle warehouse fulfilment and has attracted additional capital from investors including iRobot.

Zhongnan has contributed to the series B1 round, having previously backed a series A, as co-working spaces provider Mixpace prepares to expand into additional cities.

Abbott has contributed to the $18m second tranche of diabetes management technology developer Bigfoot Biomedical's latest round.

The emerging markets-focused online lender has raised debt and equity financing in a series B round featuring CreditEase Fintech Investment Fund.

Proceeds from the round, which included Lilly Asia Ventures, will be used to advance Tempest Therapeutics' lead enzyme inhibitor into the clinic.

The furniture retailer led SoftBank-backed home furnishing e-commerce and modelling platform 3vjia's $47.7m series B round.

Recruitment portal Seek co-led a $6.1m round that included existing backer AMP, with the capital to go to hiring and research and development.